The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to NSE-FAST®, the first rapid blood test designed to aid in the diagnosis of acute ischemic stroke.
A Cornell-led study is challenging a decades-old explanation for how chromosomes exchange genetic material within the biological process that forms eggs and sperm in mammals.
Marx will establish and serve as inaugural director of the Cornell Center for Entrepreneurship and Innovation, to boost university efforts to commercialize breakthrough scientific discoveries.
A $13.3 million grant from the NIH will support efforts to reveal how immune cells communicate within living tissues, which could shape new approaches for treating inflammatory diseases, autoimmune disorders and infections.
The CCF provides catalytic seed funding to spark pioneering applied research to advance wildlife conservation solutions. The fund prioritizes initiatives that improve the health of free-ranging wildlife and/or solve environmental problems via a One Health lens.
Thirteen Cornell students will spend the summer advancing new technologies for agriculture after receiving 2026 Research Innovation Fund awards from the Cornell Institute for Digital Agriculture.
The Center for Technology Licensing brought together Cornell inventors in Ithaca and at Weill Cornell Medicine for Bearers of Innovation: A One Cornell Celebration, recognizing CTL-connected inventors from the past two fiscal years.
Andrew Flyak, assistant professor in the Department of Microbiology and Immunology in the College of Veterinary Medicine, has been named a 2026 Pew Scholar in the Biomedical Sciences.
